Skip to Main Content

5,112

Views

5

CrossRef citations to date

0

Altmetric

Pharmacology

Oral, intranasal, and intravenous abuse potential of serdexmethylphenidate, a novel prodrug of d-methylphenidate

Megan J. Shrama Altreos Research Partners, Inc, Toronto, Canada;b Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada

,

Beatrice Setnikb Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada;c Altasciences, Laval, Canada

,

Lynn Websterd Lifetree Medical, Salt Lake City, UT, USA

,

Sven Guenthere KemPharm, Inc, Celebration, FL, USA

,

Travis C. Micklee KemPharm, Inc, Celebration, FL, USA

,

Rene Braeckmane KemPharm, Inc, Celebration, FL, USA

,

Jaroslaw Kanskie KemPharm, Inc, Celebration, FL, USA

,

Andrea Martine KemPharm, Inc, Celebration, FL, USA

,

Debra Kelshf Altasciences, Overland Park, KS, USA

,

Bradley D. Vinceg Dr. Vince Clinical Research, Overland Park, KS, USA

&

Andrew C. Barrette KemPharm, Inc, Celebration, FL, USACorrespondence[email protected]